Crystalline form of compound salt, method of preparation thereof, and uses
KR1020260121458APending Publication Date: 2026-08-11아페이론 테라퓨틱스 (홍콩) 엘티디
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- KR1020267021061
- Authority / Receiving Office
- KR · KR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-02-26
- Filing Date
- 2025-02-25
- Publication Date
- 2026-08-11
Smart Images
Figure PCT00020_ABST
Abstract
The present invention provides a crystalline form of (S)-4-amino-N-methyl-N-(6-(trifluoromethyl)-2,3-dihydrobenzofuran-3-yl)imidazo[1,5-a]quinoxalin-8-carboxamide (hereinafter referred to as "Compound I") salt and a method for preparing the same, a drug composition containing the salt of Compound I, and a use of the salt of Compound I in the manufacture of PRMT5 inhibitor drugs.
Need to check novelty before this filing date? Find Prior Art